Closed · RFA-HL-10-021 · CFDA 93.839 · Discretionary
Innovators in Hemoglobinopathies Academic Career Development Award (K07)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $414K
- Award range
- Closed
- Status
- September 14, 2010
- Close date
- -
- Expected awards
The verdict
Innovators in Hemoglobinopathies Academic Career Development Award (K07) is a closed discretionary listing from National Institutes of Health that offered Up to $414,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $414K
- award range
- Closed
- application status
- 93.839
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
Innovators in Hemoglobinopathies Academic Car… is closed (last close September 14, 2010). Check the agency catalog for replacement NOFOs. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed September 14, 2010
Est. Total Funding
$2,484,000
Instrument
Grant
Description
Purpose. The purpose of the NHLBI Innovators in Hemoglobinopathies Academic Career Development Award is to provide support for salary and research costs for up to 4 years for individuals with medical or doctoral degrees in clinical fields who are not fully established investigators and who want to pursue research careers in sickle cell disease and/or the thalassemias. The primary objective of this program is to advance the research career development of clinician scientists who have implemented innovative programs for patients with sickle cell disease and/or the thalassemias but have not been on a research track. These awards will provide support to clinician scientists who would not be eligible for other NHLBI mentored K awards, i.e., K23, K01, K08, or K25 (http://www.nhlbi.nih.gov/funding/training/redbook/newintro.htm). Prospective Candidates are encouraged to contact the NHLBI staff for specific programmatic and budgetary information (see Section VII. Agency Contacts of this FOA). Mechanism of Support. This FOA will utilize the K07 award mechanism. Candidates must commit a minimum of nine person months (75%) effort to activities covered under the award. Funds Available and Anticipated Number of Awards. The NHLBI intends to commit $2.484 million total costs in FY2011 to support meritorious projects solicited through this RFA. The NHLBI expects to award 6 grants for a total of $9,936,000 in funds over the 4-year project period.
Market-open applicant set · includes for-profit door
The eligibility set for Innovators in Hemoglobinopathies Academic Car… includes a for-profit door among 6 printed types (Public / state-controlled institutions of higher education; Nonprofits with 501(c)(3) status (other than IHEs); Nonprofits without 501(c)(3) status (other than IHEs); Private institutions of higher education; +2 more). Competitive traffic can include commercial applicants alongside other listed classes. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). Only 50 other National Institutes of Health listings share this exact eligibility-code string (0% of 12,420).
- Code 06
- Public / state-controlled institutions of higher education
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Innovators in Hemoglobinopathies Academic Car… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.839 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |